Before an Ayurvedic Medicine Reaches Patients: Understanding Clinical Trial Requirements in India

Introduction

There are some reports on Ayurveda describing it as one of the oldest medical system in the world. It originated in India and its purpose was to balance the internal systems in the body with natural therapies and regimen, dietary habits etc. Ayurveda uses numerous herbals, mineral or natural ingredients for the treatment of diseases and several medicines developed for the purpose are still in use. Ayurveda is considered as one of the ancient traditional systems of healing.

Today, the medical systems are mainly driven by the principles of evidence-based medicine where products/ medicines should have scientific evidence to demonstrate their safety and efficacy before being put to the usage by human beings (by either practitioners or general public). Not only synthetic medicines but even the alternative traditional systems like Ayurveda should not be exceptions to this.

The commercialization of the Ayurveda and its products have increased with time. It is used and sold in India and outside India too. So, it is of importance to evaluate them with scientifically. In the present era of demand for scientific evidence the Ayurveda medicines are also put to test by conducting a clinical trial for their efficacy and safety before use.

However, clinical trial in Ayurveda drugs faces many difficulties as the traditional system consists of multiplicity of drugs in one formulation, traditionally obtained information on herbs, use in the local population etc. Also, in contrast to synthetic drugs in which generally only one ingredient is the source of action in Ayurveda drugs, many ingredients contribute to the action of the drug or remedy.

In order to regulate Ayurveda medicine, it is necessary that these medicines undergo clinical trials before reaching to patient. The Government of India has established a legal framework to govern clinical trial of Ayurvedic medicines, which comprise the rules, regulation, guidelines, and provisions contained in the Indian Medical Degrees Act, Drugs and Cosmetics Act, Indian Medical Council Act etc. This legislation ensures patient safety and the ethical conduct of trials.

 

Regulatory Framework Governing Clinical Trials of Ayurvedic Medicines in India

Regulatory Landscape of Ayurvedic Medicines The regulation of Ayurvedic medicines in India has a few differences when compared with those for modern conventional drugs. However, similar to them, they are also regulated by the Government. Ayurveda medicines are primarily handled by the Ministry of AYUSH which promotes and regulates ancient systems of medicines which include Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy.

The legal basis of the regulation of Ayurvedic medicines in the country can be traced to the provisions laid down in the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945. The laws provide specifically for the ASU (Ayurvedic, Siddha and Unani) drugs, and various other guidelines and mechanisms have been devised over the time in this regard in matters pertaining to research, quality control, manufacturing, clinical trials etc. The regulation of Ayurvedic medicines in India emphasizes the evidence based scientific validation. Whereas for other systems the evidence based on clinical trials based on the principles and the established medical practice form the basis for making a therapeutic claim, the classical Ayurvedic literature, historical usage and time-tested traditional experience serve as base for making a claim of therapy, for other ancient medicines including the ASU system the guidelines laid by authorities focus on the establishment of evidence-based validation. The clinical trials should be of an appropriate design to assess the safety and efficacy of the formulation/drug. Keeping in pace with the evolving international standards of clinical research and its adapted applicability to Indian systems of medicine, specific clinical research standards and guidelines for Ayurveda, Siddha and Unani drugs have been established.

The good clinical practices guidelines for Ayurvedic, Siddha and Unani medicine are aimed at ensuring adequate protection to the rights, safety, dignity and well-being of the human participants and in providing public confidence in the integrity and the ethical quality of clinical research. Clinical trial can begin after the ethics committee has approved the proposal. Ethics Committees are expected to safeguard the rights and the welfare of participants, and that risks are balanced by the anticipated benefits, that the research is ethical and of acceptable quality in design and methodology. Many studies will have to be registered at the Clinical Trials Registry – India (CTRI). Registered trial helps in maintaining the transparency and integrity of the clinical trials by ensuring accessibility of trial information, thereby preventing publication bias.

Thus, there is a comprehensive system in place for the regulation of clinical trials for Ayurvedic medicine which includes laws, rules, regulatory agencies, ethics committees, research institutions and various guidelines which aim at the evaluation of such drugs before introducing it to patients and consumers.

 

When Are Clinical Trials Required for Ayurvedic Medicines?

A widespread misunderstanding of Ayurvedic medicines is that every formulation needs to have gone through the same rigorous clinical trial procedure as modern medicines. However the legal position is slightly more complex than that and it is not necessarily the case that all Ayurvedic medicines need to have been subject to testing in this way. It can often be a question of the individual formulation, what is being claimed about it and what it is being used for.

Old and well established Ayurvedic formulations as described in classic Ayurvedic books are all in a special category. They have already been in use in the traditional health care system for for several decades and sometimes several centuries. Looking back, due to their long standing experience and acceptance, the regulators may not insist on the clinical investigations one would expect from a brand new drug substance.

The rules become more complicated as soon as the manufacturer uses new formulations, alters existing products, combines products or makes specific claims concerning the treatment of disease. In this situation, scientific evidence will perhaps be even more important; regulators will make demands on the manufacturer and the researcher for data in support of the safety and efficacy.

For instance, take a company that markets a new Ayurvedic product. They state that this product will improve diabetic control or have a marked reduction in symptoms of a chronic disease. This claim can affect healthcare or treatment decisions, moreover patient behaviour. Regulators may therefore be a school of thought that an addition should be proved to have the co-responding He shall change effects. Unacceptable to present all the user. In addition clinical trials are getting more and more relevant once researchers tried to prove the scientific acceptability of a treatment to the national and international markets. The targeted global consumers, practitioners, and licensing bodies are all demanding evidence based on research defined studies. Clinical trials are the tool for gaining this evidence.

There are further possible reasons where conducting a clinical trial could be indispensable. To help, or secure, a publication in the scientific journals or to achieve recognition in evidence based healthcare systems. Without validated clinical information these promising Ayurvedic formulas face an uphill task regarding acceptance in the scientific and medical community.The legal framework thus does not require a blanket rule. Whether studies are required will vary according to the characteristics of the product, the nature of the claim, the regulatory authorities’ expectations and the purpose of the investigation.

However, some organizations even undertakes elective clinical trials as being excellent scientific facts can be sometimes regarded as being qualitative, market acceptable and credible.

 

Approval Process for Conducting Clinical Trials of Ayurvedic Medicines

Running a clinical trial involves much more than just finding people to test a drug. Before even the first patient enrols, there’s a long checklist of legal and ethical requirements to meet. Getting approval Here’s the typical journey:

• Development of a research protocol – A protocol is essentially the study blueprint – defining who the researchers want to include in their trial, what they will test, how they will test it and the measures in place to keep patients safe.
• Seeking Ethics Committee approval – Before a study can proceed, it must be approved by a designated ethics committee. These committees ensure that participant rights, safety, and well-being are being protected, especially considering human participants are involved. They want to know if the risks to patients are justified, if they have all the information needed to provide consent, whether the research design makes scientific sense and if vulnerable people are being looked after properly.
• Obtaining Informed Consent – All patients participating in the trial must have given their informed consent. This means they have been provided with all the necessary information regarding the trial’s purpose, its risks, expected benefits, and any alternatives to treatment – and they have willingly agreed to take part.
• Registration with CTRI – Depending on the trial type, the researchers will need to register their study in the Clinical Trials Registry – India (CTRI). This registration will make information on their study public. Researchers cannot keep trial information private, and publish only results they are happy with; the registry gives an overview of all active research.
• Documentation of every aspect – Investigators need to keep meticulous records about participants (from their enrolment, the drugs they were prescribed, to any adverse events) in order to accurately reflect and prove the course of the study.

 

Ethical Requirements in Ayurvedic Clinical Trials

Ethics is a critical consideration in all types of medical research, and clinical trials of Ayurvedic medicine are no different. There are countless examples from history where medical experiments have been conducted unethically and caused suffering to the subjects. Therefore, modern clinical research practices now follow a system in which the subject’s welfare is prioritized over the investigator’s quest for scientific advancement.

• Respect for persons- This ethical principle demands that individuals have the autonomy to participate voluntarily in a research study. The researcher can no longer force, deceive, or manipulate the subjects to be included in the research study.
• Informed consent- Related closely to the above, research subjects must be provided with sufficient information in a language they can comprehend before being asked to participate in a clinical study. Information cannot be concealed in highly technical jargon in order to obscure facts.
• Beneficence- This principle involves researchers trying to maximize the benefits of the research for the subjects and minimize the potential risks of the research to the participants. Beneficence requires that the risk to the subjects be in proportion to the benefits of the study.
• Justice- The risks and benefits of research must be fairly distributed. Certain groups should not be targeted or enlisted for the study simply because they are more economically vulnerable or easily accessible.
• Special protections- When research subjects are vulnerable in some way-such as children, the elderly, or the mentally incompetent-researchers must ensure special precautions are taken to protect their rights and well-being. Ethics Committees will evaluate these protections carefully.
• Confidentiality- Clinical trial participants disclose personal information. Researchers must protect the privacy of their patients to the maximum extent possible. These principles of ethics are no more separate from the law; in fact, they have become a fundamental part of it.

 

Challenges in Conducting Clinical Trials for Ayurvedic Medicines

Clinical trials are essential for ensuring the validity and safety of Ayurvedic medicines, but they are not always a simple task. Researchers in this field commonly face particular obstacles which may not apply to the same extent to studies of conventional medicine.

1. Difficulty due to Ayurvedic formulation: Many of the commonly available formulations in Ayurvedic medicine are complex, containing numerous compounds which together offer a holistic therapy. In contrast, conventionally developed pharmaceuticals contain single active agents and it can be harder to evaluate compounds when a multitude are combined in one product.
2. Problem with standardisation: One factor vital in clinical studies is uniformity. A researcher or a clinician requires that everyone should receive an identical dose of exactly the same substance. Natural substances may vary according to where they were grown and when harvested, the conditions under which they were prepared, or stored. It can be problematic to guarantee a consistent product for a clinical study.
3. Discrepancies between existing scientific methodology and Ayurvedic therapeutic approach: Methodology for clinical studies is often designed to deal with single compound formulations for uniform prescription. Ayurvedic therapies are, as mentioned previously, highly individualised, meaning clinical methodologies need careful adaptation to be relevant.
4. Financial limitations: Large-scale clinical studies can be costly and although conventional drug manufacturers often have very substantial research funds to spend, many Ayurvedic manufacturers and institutions are small and may have great difficulty raising enough money for robust clinical testing.
5. Perception by general public: While the interest of the public has grown for evidence based on traditional medicine, the opinions of those in support and those in opposing are diverse. Some people may support traditional medicines and do not believe that there is any need to apply the same rigorous research methods. Others may be sceptical and demand the most rigorous form of evidence. These views can make the process of obtaining consent for clinical trials harder.

Case Study: Clinical Evaluation of an Ayurvedic Formulation for Diabetes Management

The pragmatic importance of clinical trial regulations can be illustrated with a conceptual example: A pharmaceutical firm develops a new Ayurvedic product which they hope will help to treat Type 2 Diabetes, as it may potentially control blood sugar and improve metabolic health. To make such claims about the product’s potential benefit in the marketplace, the firm needs to demonstrate efficacy through a well-conducted clinical trial.

The researchers begin the process by designing a research protocol outlining the research question, methodology, selection of participants and the expected outcomes. After this process the study is submitted to an ethics committee for their consideration of whether the study design is sufficiently safeguarding the patients’ interests. Following ethics committee approval, the trial is registered and participants are then recruited from an appropriate pool. Selected patients receive comprehensive information on the research trial before signing the informed consent form.

During the clinical trial, patients are closely supervised and researchers systematically collect data on their progress and their response to treatment as well as any adverse events encountered. At the end of the trial the results are compiled and evaluated; if they show promise for the drug’s utility and safety they can serve to form a basis for marketing claims, publication in peer-reviewed scientific literature and later regulatory approval. Such trials serve to form a bridge between folk knowledge and scientific scrutiny.

 

Advantages and Disadvantages of Clinical Trial Requirements for Ayurvedic Medicines

Advantages

Some key benefits of clinical trials for Ayurveda products include:

1. Improved public trust- As it shows product reliability and safety to consumers, people will more likely believe in the effectiveness and safety of products that come with supporting evidence.
2. Risk reduction- These trials identify side effects or safety issues of a product even before its release into the public space.
3. Wider acceptance- In the international market or in healthcare sectors, people see the products through clinical evidence as trustworthy.
4. Promotes innovation- While proving the existing ones, Ayurveda companies can experiment on improved formulations and test the use of new therapies based on clinical trials.
5. Increased accountability- Manufacturers must verify the claim through tangible evidence rather than solely by way of marketing claims.

Disadvantages

Though it all seems advantageous to manufacturers and ultimately the patients and providers, there are limitations and hindrances to clinical trials of Ayurveda.

• The costs and the duration of clinical trials often prove to be a barrier for smaller manufacturers who do not have financial resources or infrastructure required for undertaking such research trials.
• The regulatory process for clinical trials, product development, and approval can be tedious and lengthy, taking years to complete the entire process and bring the product to the market.
• Researchers contend that the conventional clinical trial models don’t adequately capture the holistic and individualized characteristics of Ayurvedic therapy, which may make certain aspects challenging to assess through such methods.

However, on the whole, majority concur that the advantages of a scientific backing do outweigh these restrictions.

 

Frequently Asked Questions (FAQs)

Do all Ayurvedic medicines in India need clinical trials?

Not necessarily. The extent of clinical testing required depends on the product, regulatory needs, and marketing claims.

Which authority looks after the Ayurvedic medicines in India?

Ayurvedic medicines in India are governed by the Ministry of AYUSH, in addition to relevant provisions in the Drugs and Cosmetics Act, 1940 and related rules.

Why is the issue of informed consent important in Ayurvedic clinical trials?

It’s a prerequisite for the ethical conduct of clinical trials as participants must be willing to participate on their own after knowing everything about the study including risks and benefits.

What is the role of an Ethics Committee?

The role of an ethics committee in clinical trials is to review and approve studies to safeguard participants’ welfare, rights and safety.

Could clinical trials contribute to increase the acceptance of Ayurvedic medicines internationally?

Possibly. Scientific data resulting from well-conducted clinical trials could help bolster the acceptance of Ayurvedic products in various international health care systems.

 

Conclusion

Ayurveda still constitutes one of the most vital parts of India’s heritage of health care. With increasing interest in alternative systems, it becomes a prime responsibility of policy-makers to address demands of scientific verification. Clinical trial is an acceptable way of measuring the efficacy and safety of Ayurvedic medicines without eroding the trust of the people in health delivery systems. The regulatory framework of India, under different authorities attempts to take care of the need for balancing two aspects: On the one hand is the wisdom evolved by our ancestors; on the other hand, is the need for a modern system of scientific procedures that safeguard the people’s interest and a health-delivery system based on solid evidence. Regulatory requirements for Ayurvedic trials consist of a range of factors from regulatory approval to informed consent, ethical review, registration, recording and protecting the subject.
However, as the fields of both science and traditional wisdom get increasingly interwoven in future, one can hope that Ayurvedic research with the aid of clinical trial would help validate claims regarding Ayurvedic remedies with regard to their efficacy, safety and long-term effects. There are a number of issues regarding methodology, financing and standardization, yet, the future seems bright.